Roger G. Ulrich - Concepedia

Author

Roger G. Ulrich

W.E. Upjohn Institute for Employment Research

Also Known As

R G Ulrich, R ULRICH, R Ulrich, R. G. ULRICH, R. G. Ulrich, R. Ulrich, R.G. ULRICH, R.G. Ulrich, ROGER G. ULRICH, Roger G Ulrich

139

Publications

9.2K

Citations

H-Index

139

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research Rosetta Stone (United States)Abbott Fund Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy

About

Roger G. Ulrich is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, liver physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	43	3.8K
2	Natural Sciences	14	15	1.4K
3	Health Sciences	11	12	525
4	Engineering	3	3	490
5	Public Health	1	1	926

Roger G. Ulrich

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
Mapping the Genetic Architecture of Gene Expression in Human Liver Eric E. Schadt, Cliona Molony, Eugene Chudin, PLoS Biology GeneticsHuman PolymorphismCandidate Susceptibility GenesMolecular BiologyGene Characterization	2008	926
CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability Brian J. Lannutti, Sarah Meadows, Sarah E.M. Herman, Blood	2010	712
Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia Jennifer R. Brown, John C. Byrd, Steven Coutré, Blood	2014	583
Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Keith B. Glaser, Michael J. Staver, Jeffrey F. Waring, PubMed Histone ModificationsHdac InhibitorsEpigenetic ChangeMultiple Histone DeacetylaseGene Expression Profiling	2003	524
PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice Bradley A. Zinker, Cristina M. Rondinone, James M. Trevillyan, Proceedings of the National Academy of Sciences	2002	412
Clustering of Hepatotoxins Based on Mechanism of Toxicity Using Gene Expression Profiles Jeffrey F. Waring, Robert A. Jolly, Rita Ciurlionis, Toxicology and Applied Pharmacology EngineeringHepatologyBiochemistryPredictive ToxicologyMedicine	2001	377
Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile Tjeerd Barf, Todd Covey, Raquel Izumi, Journal of Pharmacology and Experimental Therapeutics	2017	357
Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity Jeffrey F. Waring, Rita Ciurlionis, Robert A. Jolly, Toxicology Letters PathologyGene Expression ProfilesToxicological MechanismOxidative StressToxicology	2001	317
Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Rolf F. Kletzien, Sophie Clarke, Roger G. Ulrich Molecular Pharmacology	1992	280
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver Xia Yang, Bin Zhang, Cliona Molony, Genome Research	2010	272

Page 1